• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
  • Login
  • Register
Author = Kamal Mohammadifard
Number of Articles: 2
Thermodynamic and reactivity descriptors Studies on the interaction of Flutamide anticancer drug with nucleobases: A computational view

Volume 4, Issue 1, January 2021, Pages 54-65

10.22034/crl.2020.259697.1093

Maedeh Kamel; Kamal Mohammadifard

  • View Article
  • PDF 1.64 M

Theoretical insights into the intermolecular and mechanisms of covalent interaction of Flutamide drug with COOH and COCl functionalized carbon nanotubes: A DFT approach

Volume 3, Issue 1, January 2020, Pages 23-37

10.22034/crl.2020.221149.1039

Maedeh Kamel; Ali Morsali; Heidar Raissi; Kamal Mohammadifard

Theoretical insights into the intermolecular and mechanisms of covalent interaction of Flutamide drug with COOH and COCl functionalized carbon nanotubes: A DFT approach

  • View Article
  • PDF 1.18 M

Chemical Review and Letters
  • Articles in Press
  • Current Issue

Journal Archive

Volume 6 (2023)
Volume 5 (2022)
Volume 4 (2021)
Volume 3 (2020)
Volume 2 (2019)
Volume 1 (2018)

Explore Journal

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

Latest News

COPE

“This journal is following of Committee on Publication Ethics (COPE) and complies with the highest ethical standards in accordance with ethical laws”.

 

The IJCCE site and its metadata are licensed under a Creative Commons Attribution 4.0 International License.

The Chemical Review and Letters site and its metadata are licensed under a Creative Commons Attribution 4.0 International License.

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

  • © Journal Management System. Powered by ejournalplus.com